Navigation Links
Published Results Show Denosumab Superior to Zometa® in Delaying or Preventing Bone Complications in Patients With Bone Metastases From Advanced Breast Cancer
Date:11/8/2010

;Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product.  Further, preclinical results do not guarantee safe and effective performance of product candidates in humans.  The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models.  The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures.   Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market.  Our business may be impacted by government investigations, litigation and products liability claims.  We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and h
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Study Published This Week in Alzheimers & Dementia: The Journal of the Alzheimers Association Shows that Algal DHA Improved Memory and Learning in Healthy Adults Age 55 and Older
2. Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
3. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
4. New Study Published in Journal of Drugs in Dermatology Finds Artefill Effective in Treating Atrophic Acne Scars
5. Ground Breaking Findings on Understanding Cancer Published in the Current Issue of Science
6. Phase III Data Showing Improved Survival With Jevtana® (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet
7. Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine
8. Updated Phase 2 Data With Flutemetamol Published in Annals of Neurology
9. First AXL1717 Clinical Data From Ongoing Phase I/II Study in Cancer Patients has Been Published
10. New Report World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015) Published By MarketsandMarkets
11. Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 03, 2015 Research ... addition of the "Investigation Report on China,s ... The clinical demand for steroid drug ... and good efficacy especially its extended use in ... recent years. Progesterone, a natural progestogen produced ...
(Date:9/3/2015)... , Sep. 03, 2015 ... of the "Investigation Report on China,s Trastuzumab Market, ... by Genentech, trastuzumab was approved by FDA to be ... trade name of Herceptin, a major product of Roche. ... 6.56 billion around the world. After entering ...
(Date:9/3/2015)... 2015  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... present at the CL King 13 th Annual ... at 11:00 a.m. ET. The conference will be held ... New York City . Abaxis, Inc. ...
Breaking Medicine Technology:China Progesterone Market Investigation Report 2015-2019 2Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2
... CVS ) today announced that Troyen A. Brennan, MD, ... company, has been named to the National Commission ... will assess how physicians are paid, and how pay incentives ... )   The commission is sponsored by the ...
... 5, 2012  CVS/pharmacy is informing pharmacy customers about the ... their prescriptions to help them on their path to ... policy research with Harvard University and Brigham and Women,s ... healthy and save money. For example, patients who use ...
Cached Medicine Technology:CVS Caremark's Chief Medical Officer Troyen Brennan is Named to the National Commission on Physician Payment Reform 2CVS/pharmacy Helping People on Their Path to Better Health Through Improved Medication Adherence 2
(Date:9/3/2015)... , ... September 03, 2015 ... ... a leading provider of comprehensive eating disorder treatment for adults and adolescents ... that Ileana Calinoiu, MD has joined the medical treatment team. As a ...
(Date:9/3/2015)... ... , ... Global Vision , the world leader in the development of ... and artwork inspection solutions, ScanProof and ArtProof at Packaging Innovations 2015. ... booth #F33 , Be the first to get a sneak peek of Intelligent Proofreading. ...
(Date:9/3/2015)... ... ... Hunters Creek Retrievers is again honored to salute America's military ... Celebrate Fall 2015 with unlimited Free Hugs and K9 Kisses from a premiere sporting, ... with an extra big smile. , This adorable trained Lab Pup is now ...
(Date:9/3/2015)... ... ... A scar is an unavoidable result of incision or injury to the skin. Unsightly as ... itself. The appearance of a scar is dependent on many factors – the size and ... scars fade to near invisibility on their own over a period of months,” says ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... team will be participating at the highly anticipated Mississippi Gulf Babypalooza on September ... coming from all over, from Gulfport, Biloxi, and beyond. We will be discussing ...
Breaking Medicine News(10 mins):Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2
... Global Campaign to Raise Awareness of Hunger and,Funds for ... 10 Friends of the World,Food Program (Friends of ... a global consumer campaign that will benefit the United,Nations ... spearheaded,by Yum! Brands, the world,s largest restaurant company in ...
... Ala., Oct. 10 Aeon Bioscience,Inc. today ... its key,collaborators, Brookwood Pharmaceuticals, Inc. by SurModics, ... develop improvements in drug-eluting stent,technology for the ... was formed as a collaborative enterprise between,Brookwood ...
... WARREN, Pa., Oct. 10 Just one week after,Cover ... introduced in the Legislature, Governor Edward G.,Rendell today stopped ... Insure.",The five-day, nine-stop tour will highlight the need to ... location of today,s event,has the 3rd highest rate of ...
... Thomson,Scientific, part of The Thomson Corporation (NYSE: ... information solutions to the worldwide research and,business communities, ... Journal of Medicine (NEJM) has selected ScholarOne,s,Manuscript Central ... New England Journal of Medicine is a weekly ...
... eHI Blueprint Offers Multi-Stakeholder Consensus on a Shared Vision, ... ... Through Information Technology, WASHINGTON, Oct. 10 Today the ... Common Action, which represents multi-stakeholder,consensus on a shared vision and ...
... Americans have difficulty understanding and acting on health information, ... Institute of Medicine. Misinterpreting instructions printed on drug ... injury or even death. For example, researchers have ... has been interpreted in multiple ways by patients. ...
Cached Medicine News:Health News:Friends of WFP Welcomes 'World Hunger Relief Week' 2Health News:Aeon Bioscience Continues Development of Drug Eluting Stents 2Health News:Aeon Bioscience Continues Development of Drug Eluting Stents 3Health News:Aeon Bioscience Continues Development of Drug Eluting Stents 4Health News:Governor Rendell Launches 'Tour to Insure' in Warren County; Urges Passage of Plan to Give Access to Affordable Health Insurance 2Health News:Governor Rendell Launches 'Tour to Insure' in Warren County; Urges Passage of Plan to Give Access to Affordable Health Insurance 3Health News:New England Journal of Medicine Selects ScholarOne's Manuscript Central for Online Peer Review 2Health News:New England Journal of Medicine Selects ScholarOne's Manuscript Central for Online Peer Review 3Health News:eHealth Initiative Releases Blueprint Representing Consensus on an Action Plan for Transforming U.S. Healthcare Using Health IT 2Health News:eHealth Initiative Releases Blueprint Representing Consensus on an Action Plan for Transforming U.S. Healthcare Using Health IT 3Health News:eHealth Initiative Releases Blueprint Representing Consensus on an Action Plan for Transforming U.S. Healthcare Using Health IT 4
Ruschelit® PVC. Murphy eye-nasoral. X-ray opaque line. Graduated. Single use. Sterile...
Ruschelit® PVC. Magill tip - nasoral. X-ray opaque line. Graduated. Single use. Sterile...
... Set® Tube with stylet inside. Sterile, ... uncuffed Rusch endotracheal tube with a ... use saving you time and storage ... for easy identification and has a ...
... PVC. Murphy eye-nasal. High volume/low pressure ... For improved surgical access. Designed to ... incorporating a preformed curvature. Thin-walled, large ... adapts to the anatomical situation at ...
Medicine Products: